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Gene profiling of Japanese medaka (Oryzias latipes) was performed using an oligonucleotide DNA microarray representing 22,587 TIGR O.
latipes gene indices (OLGIs). The average correlation coefficients for gene expression between individual mature fish were high (>0.95) for both
female and male, indicating that the physiological status of medaka is highly reproducible under prescribed growth conditions. Of the 22,587
OLGIs, 2575 showed significant differences in expression between female and male. Exposure to 17β-estradiol (E2) revealed 381 E2-responsive
OLGIs in male medaka. Feminization and male-dysfunction factors of the E2-treated males calculated using the combination of Pearson
correlation coefficient and Euclidean distances indicate that E2 treatment “weakly feminized” male medaka, while male physiological functions
were not significantly disrupted. This study demonstrates the possibility of using medaka microarrays to estimate the overall effects of hormonally
active chemicals.
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Abstracts (http://www.cas.org/cgi-bin/regreport.pl). It has been
proposed that tens of thousands of chemicals are discharged into
and presumably accumulate in our environment. Among these,
chemicals termed environmental pollutants can function
directly as toxins to various organisms or indirectly as modifiers
of normal biochemical processes. For example, there is a
growing concern that certain chemicals, termed endocrine
disruptors, may change the reproductive status of organisms by
adversely affecting endocrine systems [1].
Technological advances in analytical techniques have given
researchers the ability to detect lower concentrations of
chemicals in animal tissues, surface water, sediments, and air.
However, the concentrations of chemicals, especially inAbbreviations: TC, tentative consensus; EST, expressed sequence tag; ET,
expressed transcript; TIGR, The Institute for Genomic Research; OLGI, TIGR
Oryzias latipes (Japanese medaka) gene index (TCs, ESTs, and ETs).
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doi:10.1016/j.ygeno.2006.03.023complex mixtures, do not correlate well with the degree of
toxicity to organisms. To address this problem, a variety of
bioassays and biomarkers have been developed to evaluate the
effects of a chemical on the survival, development, growth,
reproduction, and physiology of various organisms [2,3].
Molecular and biochemical techniques have also been used to
investigate toxicity and elucidate chemical toxicity mechan-
isms. Nonetheless, classical toxicological methods, which
measure a limited number of endpoints, often cannot provide
adequate insight into the mechanisms behind complex modes of
toxicity and generally offer limited predictive value in long-
term risk assessment for clinical trials. Thus, there is clearly a
need for development of more effective preclinical and/or
clinical screens for examining the toxic effects of chemicals.
Since changes in the patterns of gene expression within a
living cell can reflect changes in the physiological state,
detection of perturbations in gene expression should allow the
evaluation of multiple types of toxicity, from acute toxicity to
endocrine disruption. Toxicogenomics, the use of comprehen-
sive gene expression changes to evaluate chemical toxicity,
greatly expands the scope and depth of this approach in
242 K. Kishi et al. / Genomics 88 (2006) 241–251toxicology [4]. Toxicogenomic gene expression studies have
been facilitated by the development of microarray technologies.
The advent of DNA microarrays in the mid-1990s [5,6]
provided a means for analyzing the expression of thousands of
genes simultaneously. This advantage allows toxicologists to
take a whole-organism perspective on toxicity, in that the effects
of a substance on the expression of virtually all known genes
can be assessed within a single microarray [4]. DNA microarray
can also be used to assess physiological reproducibility: Since
mRNA expression profiles reflect an organism’s physiology,
the ability to measure accurately changes in mRNA expression
levels promises high reproducibility between biological
experiments.
The Japanese medaka (Oryzias latipes), selected by the
Japanese Ministry of the Environment as an indicator species
for ecotoxicological study, has been a focus species in bioassay
research. Standardized procedures for medaka bioassays are
recommended and published by the Japanese Ministry of the
Environment (http://www.env.go.jp/chemi/kagaku/). The appli-
cability, precision, and reproducibility of these procedures,
which are based primarily on methods developed by scientists
studying medaka, need to be evaluated and standardized to
obtain reproducible and comparable experimental results within
the medaka research community.
Medaka is also widely accepted as an experimental model
system for development, histology, and sexual differentiation
research. Like many other fish, the sex of medaka is XX/XY
coded and can be easily distinguished by external sex
characteristics [7]. Detailed characterizations of gonadal
differentiation and morphology are available to serve as the
standard for detecting aberrant histopathological effects [8].
Interestingly, the sex of medaka can be functionally reversed if
androgens or estrogens are applied during a sensitive period of
embryonic or juvenile development [7,9]. In addition, cDNAs
of sex-specific genes like vitellogenin [10] and choriogenin H
[11] have been cloned and sequenced and can be used to analyze
sex-specific gene expression. The Y-chromosome-linked sex-
determination gene DMYof medaka was recently identified, the
first example among teleost fish [12]. Large-scale gene
expression analyses have been applied to medaka developmen-
tal biology [13,14]. These experimental resources and devel-Fig. 1. Scatter plots of medaka microarray analyses of mRNA expression: male 2 vopmental features make medaka an ideal vertebrate animal
model to study the effects of chemicals on sexual differentiation
and development.
The objective of this study was to test the efficacy of medaka
bioassay standard procedures using an oligonucleotide-based
medaka DNA microarray containing 22,587 probes. Our
previous studies using yeast cDNA microarrays had shown
high correlation coefficients of gene expression among
independently cultured cells [15]. Therefore, we first confirmed
the high correlation coefficients of gene expression in
individual medaka grown under the standard procedures.
Second, we exposed male medaka to 17β-estradiol (E2), a
female sex steroid hormone, and assessed E2-induced changes
in mRNA expression with a medaka DNA oligonucleotide
microarray. Furthermore, to identify the genes responsible for
feminization of male fish by estrogenic chemicals, changes in
the mRNA expression profile of the E2-exposed fish were
compared with the normal patterns of sex-specific gene
expression in medaka. Based on the mRNA expression profiles,
assessment of the degree of feminization/demasculinization
using the combination of Pearson correlation coefficient and
Euclidean distances was attempted to estimate the impact of
hormonally active chemicals, such as E2.
Results
Physiological reproducibility of standard procedure
The medaka array contained 22,587 TIGR (The Institute for
Genomic Research) O. latipes (Japanese medaka) gene indices
(OLGIs) [10,085 TCs (tentative consensuses), 12,333 singleton
ESTs (expressed sequence tags), and 169 singleton ETs
(expressed transcripts)], with four probes for each OLGI. The
expression level of each OLGI was defined as the average of the
signal intensities from the four probes hybridized to the OLGI.
With this microarray, we looked for differences in gene
expression between individual male and female fish (Fig. 1).
As mentioned in the introduction, male and female fish are
distinguishable by external secondary characteristics [7]: Male
dorsal and anal fin rays are longer and thicker than those of the
females and have a characteristic notch at the posterior of thes male 1 (left), female 2 vs female 1 (center), and female 1 vs male 1 (right).
Table 1
List of correlation coefficients among individual medaka
Sample Female 1 Female 2 Female 3 Male 1 Male 2 Male 3 Male 4 Male 5 Male 6
Female 1 1 0.99 0.96 0.92 0.91 0.88 0.89 0.9 0.91
Female 2 1 0.96 0.91 0.91 0.88 0.88 0.89 0.91
Female 3 1 0.89 0.88 0.91 0.84 0.85 0.88
Male 1 1 0.99 0.95 0.96 0.96 0.98
Male 2 1 0.95 0.96 0.96 0.98
Male 3 1 0.88 0.91 0.94
Male 4 1 0.96 0.97
Male 5 1 0.97
Male 6 1
Fig. 2. The number of OLGIs expressed in a sex-specific manner and in response
to 17β-estradiol (E2) shown in a Venn diagram. The upper circles represent
female-specific OLGIs and E2-up-regulated OLGIs, while the bottom circles
encompass male-specific OLGIs and E2-down-regulated OLGIs. The regions
are classified: (a) and (b), sex-specific OLGIs regulated by E2; (c) and (d), sex-
specific OLGIs unrelated to E2; (e) and (f), E2-responsive OLGIs but non-sex-
specific.
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papilla is a paired protuberance between the anus and the
oviduct opening. Alternatively, males feature a single-lobed
prominence between the anus and the urogenitals. Correlation
coefficients of gene expression patterns among male and among
female fish are shown in Table 1. Brood stock specimens
consisted of three male and three female fishes. An additional
three different male samples were used as the untreated controls
in the E2 exposure experiment. The correlation coefficient
values were >0.96 among female fish, whereas those values
varied from 0.88 to 0.99 among male fish (Table 1). The
average of correlation coefficients among male and female
medaka were high [0.956 (n = 6) for male and 0.969 (n = 3) for
female], indicating that variances between medaka mRNA
expression profiles were small. This result implies that highly
reproducible physiological data can be obtained from medaka
maintained under the standard conditions ([2]; http://www.env.
go.jp/chemi/kagaku/).
Differential expression profiles between male and female
In contrast to the high correlation coefficients among the
male–male or the female–female comparisons, correlation
coefficients in gene expression between individual males and
females were lower (Fig. 1, Table 1). The mean of correlation
coefficients between individual males and females was 0.891.
Among the 22,587 OLGIs analyzed, we identified OLGIs
corresponding to genes preferentially expressed in either male
or female using an analysis of variance analysis (ANOVA). In
the comparisons of gene expression between male and female,
OLGIs that gave p values less than 0.05 were considered
markers for male- or female-specific genes. By this criterion,
1844 OLGIs were estimated to represent genes specifically
expressed in the female, and 731 represented male-specific
genes. The female-specific OLGIs represented sequences of
previously characterized female-specific genes such as vitello-
genin I/II, choriogenin H/L, ZP family genes (ZPA, ZPB, and
ZPC), cyclins B, FIGα, and 42Sp50 [16] (see Supplementary
Table 1; it should be noted that in this report, the TC numbers
and tentative annotations in all supplementary tables are derived
from TIGR database release 4.0). Unlike the female-specific
OLGIs, most of the male-specific OLGIs have not yet been
assigned or characterized (see Supplementary Table 2).Nonetheless, these OLGIs are good candidates for male-specific
biomarkers. These results suggest that medaka microarrays can
be used to distinguish physiological sex by analyzing the
expression profiles of sex-specific OLGIs.
17β-Estradiol-responsive genes
It has been previously demonstrated that E2 treatment causes
feminization (e.g., formation of oocytes in the testis, known as
testis–ova, and vitellogenin induction) of male medaka [17,18].
To identify changes in gene expression in response to E2,
mature male medaka were exposed to 100 ng/L E2 for 21 days
(conditions standardized by Japanese Ministry of the Environ-
ment for the vitellogenin induction assay; http://www.env.go.jp/
chemi/end/pdfs/emedaka_all.pdf), and cDNA prepared from
E2-treated male medaka was applied to the microarrays. The
average correlation coefficient among three E2-treated male
medaka microarrays was 0.980 (data not shown), again
Fig. 3. Representative OLGIs expressed in sex-specific manner and in response
to E2. A part of the OLGIs classified in Fig. 2 are shown in color according to
their expression strengths, which are from an average of six males (M), three E2-
treated males (E2), and three females (F). OLGIs with arrow indicate the
character classified as the same in Fig. 2.
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In comparisons between the gene expression levels of six
control males and three E2-treated males, we determined that E2
treatment resulted in significant changes (p < 0.05) in the signal
intensities of 381 OLGIs: signal intensities from 242 OLGIs
increased and from 139 OLGIs decreased. In general, E2-
dependent changes in gene expression were more extreme
among those sequences showing increased expression in treated
males, relative to sequences showing decreased expression.
Among the 242 up-regulated sequences, 169 were also highly
expressed in females (Fig. 2, (a), Supplementary Table 3),
whereas expression of the other 73 sequences was not
statistically different between female and male medaka (Fig.
2, (e), Supplementary Table 4). The expression levels of
vitellogenins and choriogenins were extremely high in both
female and E2-treated male medaka (see Supplementary Tables
1 and 3), whereas the expression levels of some oocyte-specific
genes (e.g., ZP family, cyclins B, FIGα, and 42Sp50) were not
significantly changed by E2 treatment (data not shown). Ninety-
one of the 139 OLGIs representing genes down-regulated by E2
treatment of males were also expressed at low levels in the
females (Fig. 2, (b), Supplementary Table 5), whereas 48 were
down-regulated only in the E2-treated males (Fig. 2, (f), see also
Supplementary Table 6). To visualize the OLGIs that were
impacted the most, representative gene expression that was
changed during feminization or unchanged by E2 treatment is
shown in Fig. 3.
Validation of changed gene expression by reverse transcription
polymerase chain reaction (RT-PCR)
To test whether the changes in gene expression seen with the
medaka microarray were reproducible by other methods, 30
OLGI sequences were selected for RT-PCR evaluation, so that
the dataset would span the entire range of the gene expression
ratios in the microarray. PCR primers for these genes were
designed to be analogous to the sequences of the medaka
microarray probes (Table 2). The same RNA samples used for
microarray analysis of females, males, and E2-treated males
were used as templates for RT-PCR. Of the 30 OLGIs, valid
quantitative PCR data could not be obtained from one OLGI,
since it generated multiple products. As shown in Fig. 4,
inductions and suppressions were in line with the microarray
data. This means that a good correlation was obtained between
the expression levels measured by microarray and RT-PCR
experiments.
Discussion
Bioassays and biomarkers have been employed to investi-
gate the toxic effects of chemicals on a variety of test organisms
[2,3]. One of the test organisms, Japanese medaka, has been an
excellent model for various studies, from mode-of-action
investigations of particular toxins to studies involving assess-
ments of sex differentiation, development, and histology [7–
9,12,19]. Tremendous resources committed to the isolation and
sequencing of medaka ESTs promise greater understandingwithin the field of medaka developmental biology [13,14].
Using the Maskless Array Synthesizer (MAS) developed by
Singh-Gasson et al. [20], a medaka oligonucleotide microarray
with 179,972 features that represent 22,587 OLGIs was recently
Table 2
Primers designed for RT-PCR of 30 OLGIs
Seq. source Tentative annotation, hit coverage Sequence (5'→ 3') (forward, reverse) Cycles
TC26038 Chaperone protein GP96, partial (59%) CGACACAAAGGCTTACGGAGAC 25
GGTAACGTTAACCACAGCAGAACT
TC25984 Hypothetical protein, partial (4%) CGATGCTTCTTTGCAGTTTGTCT 25
CGATGTACTGGCTAATGCTGATG
TC20568 Choriogenin L (fragment), complete GAAAACCTTCAGATCCTTCCAG 25
TAAGGTTGAGGAAAGGCTAGATACA
TC20765 Choriogenin H, partial (93%) TCCATATGCAGATGATCGTTACCT 25
AGCACTTCTCCAGACGATACCAC
TC25785 Vitellogenin II, complete ACGGGGAAGTCAAGGAAGAGTAT 25
ACCAATGGGTAGACAATGGTATC
TC20644 Vitellogenin I, complete TGATGGGGAAGTCAGACAAGATTA 25
AGTCCCTCAGGTCCACACTTTC
TC20402 Saxitoxin and tetrodotoxin binding
protein 1 precursor, partial (14%)
CTTACTTCATCCATATGACCGTACC
TGAAACGTTCCTCCTAAGACTGATT
25
AU179687 EST GAAGTCCTGCCTGCTTTCAAAC 25
GGATTAGGATCAAGAAATGGGAAC
TC21239 Warm temperature acclimation protein, complete ACATCATCAAAGATCGGCACAT 25
TTCAGTCCTGTCAAGTTAGCCTCTT
TC25662 MGC75578 protein (ribosome-associated
membrane protein), partial (88%)
TTTGCATCAGAAGGTGTGAAGG
AACTTTATTCAGAGAGCGGGAATG
25
TC21060 Claudin-like protein, partial (87%) CCCACTCCGGTATGCAGATT 25
GACCAGCCACAGAGACCACA
TC27741 Y box protein, partial ( 4%) AAGAAAGCTGAAGATGATCCAGAAG 25
GAGCGCAGAAGAACCACAGAAC
TC27586 Unknown, complete CCATGGGCCTGTATTCTACCAC 25
CTCAGTATTCCTGGCCCAACCT
TC21331 ZP AX, complete GAAGGACAGCAGAGTTTCAATCC 25
AACAGAATACGCCCAGAGGAGA
TC22874 Pinin, partial (3%) GGTTATGGCAGCTACTCTCAACAA 25
GTATTTGCCAACAGCCACAGAA
TC20437 Orf410, partial (3%) TGAGCTCTGCTGTTGCAGGATA 25
AGCTTGAGCAGATCCTGGCTGT
TC20797 Orla C3-1 protein, complete CATTCCTCAGTTATCCCCATTG 26
TGACATGCAAACACTCTGAACTG
TC22429 Fibrinogen β chain precursor, partial (27%) ATTAATGAGCTCAAGCCCGAAG 25
ATGTTGTTGTCGACTACGAGTCTTT
TC29032 Deiodinase type I, partial (51%) AAGAGCACCATGACCTACAATCC 25
TGCTCATTTCATCAACGACCAC
AU243616 Puff C-8 protein, partial (8%) GGACATGCACATGGTAAAGGAG 25
TGACTTAATGCGTGATTTCTCCAC
NP418658 Protamine, complete GTCCGCAGGACTCGTGTTGTT 25
TCCCCAAATGGAGGTGTGCTA
TC29125 DMY protein (male sex-determining protein), complete GCGTCAAGGCAGAGTTTGAGAG 38
GCAGCAGACATTATCCATCCAA
TC25881 Nephrosin precursor, partial (81%) GATTTCTGGACAGGAGCACAAC 25
AGCTAACATCTAGCAAAAGCATGTC
TC26524 EST GCTGTACTGAGAAACTCCTGATGG 26
CAGACTAGATGAGCACAAACAGTGA
BJ496130 EST, chymase precursor, partial (16%) GTCATTCCTCTGAAGTCAGGAACA 25
CAACACCACAAACCATCGACCT
TC26523 EST ATGACTGACGGCGTTTCAAAGA 25
TCCAGAGCCAACATCTACTTCAG
AU178086 EST, methionine aminopeptidase, partial (26%) CAAGGATGCCAAACTTCAGTGC 28
CCTCATGGGAGTCAGAGGGTAA
AU178617 EST, RNA-binding protein, partial (36%) ACTGATTCCAGCATCCCCAGAT 28
GCTGGGAAGTCTCAGAGGGAGA
TC37006 β-Actin (D89627), complete GCGTAAATACTCTGTCTGGATTGG 25
GAGTGAGCGAGAAATGTGTGGT
TC26283 Conserved protein, partial (6%) GCAAGAGCAACCAAGCCATAGT a
GGACCGTCGTACAGACCAGGAT
a This gene was eliminated for RT-PCR analysis because it generated multiple bands.
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Fig. 4. Log ratio plots comparing female/male ratios (left) and E2-male/male ratios (right) from microarrays and RT-PCRs. Ratios shown here are from expression
levels of a group average: in microarray results, n = 3 for female and E2-male and n = 6 for male; in RT-PCR results, n = 2 individuals, respectively.
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The MAS uses a digital light processor from Texas Instruments
(Dallas, TX, USA) to generate the patterns of UV light used in
the light-directed synthesis of oligonucleotides. The MAS is
capable of synthesizing probes up to 90 bases long and can
address up to 480,000 pixels in a 10 × 14 mm2 area with 1:1
imaging, theoretically enabling researchers access to nearly half
a million different oligonucleotide sequences for a variety of
applications [20]. Our primary goal, to screen for medaka genes
expressed in a sex-specific fashion and for those responsive to
E2, led us to choose whole-body sample preparation rather than
sampling from individual tissues such as liver or gonad.
We first examined the variance in mRNA expression levels
between pairs of individual whole fish using microarray
analysis. Nine individual samples prepared from three female
and six male fish were analyzed. The average correlation
coefficients among female fish and male fish, respectively, were
more than 0.95, indicating that changes in mRNA expression
among mature fish of the same sex are small (Fig. 1, Table 1).
These data also demonstrate that mRNA expression profiles
obtained by microarray analysis of mature medaka maintained
under standard protocols [2] are highly reproducible. The
reproducibility makes it an ideal tool for evaluating medaka
responses maintained in different laboratories. For example, a
microarray database reflecting the physiological state of
medaka raised under standard conditions could serve as the
basis for GLP (Good Laboratory Practice) approval by the
Japanese Ministry of the Environment. In addition, because
even the E2-treated fishes showed highly reproducible gene
expression in our results, it was conceivable that only a small
number (e.g., 3 individuals) of medaka is sufficient for
microarray analyses of a particular condition, such as
hormone/toxicant exposure, temperature, water quality, etc.
Statistically significant differences between male and female
mRNA expression levels were measured using 2575 OLGI
sequences (Figs. 1 and 2). More than 2/3 (1844) of these OLGIs
were highly expressed in female fish (see Supplementary Table
1). Among them, vitellogenin I/II and choriogenin H/L are
estrogen-regulated precursor proteins. Vitellogenins are themajor preyolk proteins in oviparous species, including teleost
fish [21]. In response to E2, they are synthesized in the female
liver, secreted into the bloodstream, and finally taken up by the
developing oocytes through receptor-mediated endocytosis [21].
Choriogenins H and L, which are precursors of a major subunit
of the zona radiata (the inner layer of the egg envelope), are also
synthesized in liver in response to estrogen, released into blood,
and then incorporated into the zona radiata in sexually matured
female fish [11,22]. The presence of mRNA for these female-
specific genes, which are not normally expressed in male fish,
demonstrates one effect of the exposure of male fish to
estrogenic chemicals [22,23]. Detection of mRNA or protein
expressed from these genes, especially vitellogenin, has been
used extensively as a biomarker for exogenous estrogenic
compounds in various fish species [22,23].
Other female-specific genes identified by microarray analysis
include egg envelope proteins, oocyte-specific RNA binding
proteins, and a transcription factor containing a basic helix-loop-
helix motif (see Supplementary Table 1). All the genes described
below were highly expressed in mature female medaka (female/
male ratio >10). One basic helix-loop-helix transcription factor,
factor in the germ lineα (FIGα), is known to play a key regulatory
role in the expression of multiple oocyte-specific genes during
oocyte development [24]. Egg envelope proteins, including zona
pellucida (ZP)-domain proteins that are common among
vertebrates, are expressed during oocyte maturation [25]. Other
factors essential for oocytematuration have been identified in fish
species (zebrafish, goldfish, and medaka). Oocyte maturation is
triggered by the activation ofmaturation-promoting factor (MPF),
consisting of cdc2 (a catalytic subunit) and cyclin B (a regulatory
subunit), following stimulation by 17α,20β-dihydroxy-4-preg-
nen-3-one (17α,20β-DP), an endogenous maturation-inducing
hormone in fish species [26,27]. Briefly, 17α, 20β-DP stimula-
tion triggers the unmasking of cyclin B mRNA and subsequent
protein synthesis. Cyclin B binding to cdc2 and activation of cdc2
by cdk7 activates MPF [26,27]. Another oocyte-specific gene
highly expressed in female medaka, 42Sp50, was originally
isolated and characterized in Xenopus laevis [28]. It is one of the
protein components of a 42S ribonucleoprotein particle that is
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function of the 42Sp50 is considered to be the long-term storage
of 5S RNA and aminoacyl-tRNA for use in oogenesis and early
embryogenesis [29].
In contrast to the large number of highly expressed female-
specific OLGIs, only two OLGI sequences were highly
expressed in male fish (male/female ratio >10-fold) (see
Supplementary Table 2). One of the highly male-specific
OLGIs, protamine, is an arginine-rich basic protein found in the
vertebrate sperm nuclei [30]. The physiological role of
protamine in medaka has been suggested to protect the
ejaculated spermatozoa from disruption by low osmotic
pressure [31]. Other male-specific OLGIs identified in this
study did not exhibit striking differences in expression between
male and female fish, nor have the functions encoded by of
these male-specific sequences been well characterized.
Although microarray analyses revealed no significant
differences between males and females for expression of
DMY or members of the DMRT gene family (data not shown),
RT-PCR results demonstrated preferential expression of DMYin
males (male/female ratio ∼4-fold), along with a low level of
DMY expression in females (data not shown). One possible
reason for this discrepancy may lie in the probes for DMYused
in the microarray design; DMY shows a high degree of sequence
similarity with DMRT1. The DMY gene is located in a 250-kb
Y-specific chromosomal region that contains the male-deter-
mining gene and the first sex-determining gene identified in
nonmammalian vertebrates [12]. The DMRT genes also are
involved in sex determination as well as differentiation in
various invertebrate and vertebrate species [32–34]. The
founding member, DMRT1, is implicated in male development
of vertebrates with species-specific differences [35]. The
sequences of DMY and DMRT1 show strong similarities, and
DMY appears to originate from a duplication of an autosomal
segment containing the DMRT1 region [36,37]. In addition,
although DMRT1 has been reported to exhibit high expression
exclusively in the testes of fish species [38,39], Ohmuro-
Matsuyama et al. [40] showed that DMRT1 in medaka is
expressed in female ovaries as well as various male tissues, with
the highest expression in testis.
Alternatively, although its function has yet to be defined,
high expression of one EST [AU243616, tentative annotation;
weakly similar to PIR|S39079|S390 puff C-8 protein—fungus
gnat (Rhynchosciara americana), partial (8%)] in male was
observed by microarray analysis (see Supplementary Table 2).
For global expression profiling using the medaka microarray,
the OLGIs listed in Supplementary Table 2, including
AU243616, might be better candidates than DMY or DMRTs
for male-specific biomarkers in mature fish.
Estrogenic chemicals such as E2, synthetic estrogens, and
alkylphenols may change the reproductive status of organisms
by adversely affecting endocrine systems [1,41,42]. In medaka,
exposure to endogenous steroid hormones or exogenous
endocrine-disrupting chemicals causes intersex (testis–ova) or
sex reversal in the gonads [17,18,43]. E2 has been shown to
induce testis–ova in male medaka at concentrations from 50 to
250 ng/L with an incidence of 100% and to induce significantamounts of hepatic vitellogenin at more than 50 ng/L after
21 days of exposure [17]. Since the Japanese Ministry of the
Environment recommends 100 ng/L of E2 as a positive control
for the 21-day vitellogenin induction assay (http://www.env.go.
jp/chemi/end/pdfs/emedaka_all.pdf), male medaka were simi-
larly exposed to E2 with the exception that glass beakers were
used instead of water-flow systems.
Microarray analysis of the E2-treated male medaka identified
381 E2-responsive OLGIs. Of the 242 up-regulated OLGIs in
E2-treated male, 169 OLGIs were also female-specific. Of the
139 OLGI sequences that showed decreased expression in E2-
treated males, 91 were also significantly lower in female (Fig.
2). These results suggest that the 260 sex-specific OLGIs
responsive to E2 are likely to be regulated by endogenous E2 in
medaka. In contrast, the 73 sequences induced and the 48
suppressed by E2 were not categorized as sex-specific OLGIs.
Although the functions of these 121 OLGIs are not well
characterized, their responsiveness to E2 may be part of a more
generalized response to the toxicity of this hormone. The
remaining sex-specific OLGIs were neither induced nor
suppressed by E2, suggesting that the expression of these sex-
specific genes may not be E2 sensitive. Results presented in our
study demonstrate the possibility of using the medaka
microarray to distinguish hormone-responsive genes from
genes responsible for other functions, such as detoxification.
Among the female-specific OLGIs, strong E2-induced
expression of vitellogenins and choriogenins was observed in
microarray analysis (see Supplementary Table 3). Since these
genes are not normally expressed in male fish, they are ideal
biomarkers for male fish that have been exposed to exogenous
estrogenic compounds [22,23]. On the other hand, E2 induction
of other female-specific genes, such as ZPs, cyclins B, FIGα,
and 42Sp50, was not detected in this study, suggesting that E2
treatment did not activate oocyte formation in testes (testis–
ova). These differences demonstrate that estrogenic compounds
do not synchronize activation of all female-specific OLGIs.
It has been argued that elevated vitellogenin levels or induction
of testis–ova may not be responsible for reproductive impairment
by estrogenic compounds [17,44]. The question then arises: Even
though E2 is known to cause feminization in medaka [17,18], to
what degree were male medaka “feminized” by the E2 treatment?
Pair-wise comparisons between the expression levels of individual
OLGI sequences (e.g., vitellogenins, choriogenins, and ZPs) cannot
comprehensively answer this question. Therefore, to assess the
degree of feminization and the degree of male dysfunction
(demasculinization) using the mRNA expression profiles obtained
in this study, we used Euclidean distance and the Pearson
correlation coefficient (Pearson CC) [45] to compute similarity
(or distance) between gene expression measures.
The Euclidean distance of a series of expression data, x = {x1,
x2, …, xn}, from origin is defined as
d ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃXn
i ¼ 1
ðxi  Px Þ2
s
ð1Þ
where x is the average value in x (in this case, the mean of
22,587 OLGIs in the male, female, or E2-treated male groups).
248 K. Kishi et al. / Genomics 88 (2006) 241–251The Pearson CC between two series of expression data,
x = {x1, x2, …, xn} and y = {y1, y2, …, yn}, is defined as
Pearson CC ¼ cosh ¼
Xn
i¼1
ðxi Px Þðyi  Py ÞﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃPn
i¼ 1
ðxi  PxÞ2
s ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃPn
i ¼ 1
ðyi  Py Þ
2
s
(2)
where θ is a vector angle between the two datasets, and x, y are
the average values in x, y, respectively (in this case, the means of
22,587 OLGIs in the male, female, or E2-treated male groups).
The Pearson CC can range between −1 and 1, with 1 indicating
complete identity between the two series, 0 indicating no
correlation, and −1 indicating negative correlations between all
loci. Euclidean distance preserves the information about the
magnitude of changes in the mRNA expression levels directly,
whereas the Pearson CC reflects the similarity in expression
patterns [45]. Thus, the Euclidean distances of the expression
datasets were calculated first, and then the Pearson CC values
were combined with the Euclidean distances to estimate the
degree of feminization and the degree of demasculinization.
To determine the degree of feminization or dysfunction of
the male, only sex-specific OLGIs were used, since other
OLGIs are likely to involve physiological functions or effects
common to both sexes and may lead to correlations pertaining
to factors other than sex-specific functions. The average
normalized expression levels for each of the 2575 sex-specific
OLGIs (Fig. 2, (a)–(d)) in males, females, and E2-treated males
were used for calculations.
Fig. 5 shows a vector diagram of spatial relationships
between male, female, and E2-treated male derived from
microarray data. The Pearson CCs, cos α, β, and γ (defined in
Fig. 5) were calculated as 0.159, 0.677, and 0.602, respectively,
and indicate only weak similarities between male and female
sex-specific OLGI expression profiles. Because changes in the
expression levels of individual sex-specific genes were not
synchronous in response to E2, the E2-male profile was
displaced from both the male and the female directions. TheFig. 5. A feminization factor (left) and a male dysfunction factor (right) determine
expression levels of sex-specific OLGIs in each group. Vector angles α, β, and γ are i
and female, respectively. All numbers shown are calculated when the Euclidean dis“feminization factor” of the E2-treated male, defined as the
distance that the E2-male “moved” from male to female
directions, was calculated as 0.342 (Fig. 5), suggesting that E2
treatment “weakly feminized” male medaka in this study.
While trying to measure the degree of damage on male
physiological function by E2 treatment, we asserted that the
distance the E2-male migrated away from the male direction
would represent the degree of male dysfunction. The “dysfunc-
tion factor” or “demasculinization factor” for E2 treatment of
males, estimated to be 0.096 (Fig. 5), suggested that E2
treatment did not significantly disrupt male physiological
functions even though various female-specific OLGIs were
dramatically induced.
It has been demonstrated that functional sex reversal in
medaka can be achieved only by hormone exposure at a
sensitive period of early development [7,9,18]. By exposing
adult males to hormones, the sex of medaka cannot be
functionally reversed even though the E2-responsive genes
(e.g., vitellogenin) are dramatically induced [22,23], and the
testis–ova are also observed in some cases [17,18,43]. In fact,
no induction of genes that are related to female structures (e.g.,
ZPs, cyclins B, FIGα) in the E2-treated male was observed in
this study. The calculated feminization/demasculinization
factors for E2-treated males also strongly indicate that the E2
treatment in this study did not sexually reverse but only weakly
feminized adult male medaka without disturbing male physi-
ological functions.
To the best of our knowledge, this is the first attempt at
estimating the impact of hormones using global mRNA
expression profiling. We propose that the combination of
Pearson CC and Euclidean distances demonstrated in this study
could be used to calculate overall effects of hormones, since
both the magnitude of changes in the mRNA expression levels
and the changes in the expression patterns are taken into
account. The magnitude of changes in mRNA expression levels,
however, varies significantly, so that distance might presumably
be overestimated by the influence of highly expressed mRNAs.
We would emphasize that although we chose whole body
preparation rather than tissue-specific analysis to establish
global gene expression profiles of medaka in response tod using Pearson correlation coefficients and Euclidean distances based on the
ndicated as the angles between male and female, male and E2-male, and E2-male
tance between the origin and the female is defined as 1.0.
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probably detect more candidates for important hormone- and
gender-specific gene expressions by avoiding dilution of the
tissue-specific RNA by other tissues. Therefore, tissue-specific
microarray analysis of hormone-dependent gene expression and
weighting genes truly responsible for sexual differentiation/
determination would be necessary to quantify accurately the
degree of feminization or masculinization in medaka caused by
hormonally active chemicals.
In conclusion, we have demonstrated that the medaka
microarray provided highly reproducible data to evaluate the
physiological state of medaka male and female and E2-
responsive gene expressions in the male. The microarray
approach thus identified signature gene subsets indicative of
differentially expressed genes in normal males and females. As
the sex-specific genes possess many feminization and male-
dysfunction markers, we calculated feminization and male-
dysfunction factors of E2-exposed males. However, to apply
this evaluation method to a wider range of hormonally active
chemicals (such as endocrine disruptors) we should clarify the
relationship between intensity of gene expression alteration and
strength of hormonal activity, because E2 is one of most severe
feminizing hormones and less feminizing agents might fall
within the level of error for microarray analysis. It should be
emphasized that although further improvements are needed in
our evaluation method, the genes identified here could serve as
potential novel biomarkers for future investigations of specific
hormonal activities in medaka and other fish models.
Materials and methods
Test organism
Japanese medaka, O. latipes (orange-red variety or “Himedaka”), were
originally purchased from Tsuchiura Goldfish Fishery (Tsuchiura, Ibaraki,
Japan) and then maintained at Japan Pulp & Paper Research Institute, Inc., for
several generations. The brood stock was maintained at 24 ± 1°C in UV-
disinfected, dechlorinated, carbon-treated tap water with a 16 h light–8 h dark
photoperiod. The fish were fed Artemia nauplii (<24 h after hatching) twice
daily. Medaka selected for this study were approximately 6 months posthatch
and fully mature. Growth conditions followed guidelines recommended by the
International Toxicity Test Protocol [2]. For microarray analysis, female and
male fish (body wt ∼400 mg; total length ∼3 cm) were collected from the
brood stock, flash-frozen in liquid nitrogen, and stored at −80°C for RNA
extraction.
Test chemical
17β-Estradiol was obtained from Sigma Chemical Industries, Ltd. (St.
Louis, MO, USA). An E2 stock solution of 20 μg/ml was prepared by dissolving
2 mg E2 in 100 ml dimethyl sulfoxide (Wako Pure Chemical Industries, Osaka,
Japan).
Exposure conditions
E2 has been reported to induce vitellogenin and testis–ova (oocyte
formation in testes) in adult male medaka at a concentration of >20 ng/L [17].
Since treatment with 100 ng/L of E2 has been used as a positive control for the
vitellogenin induction assay standardized by the Japanese Ministry of the
Environment (http://www.env.go.jp/chemi/end/pdfs/emedaka_all.pdf), we
chose 100 ng/L as the exposure concentration in the present study. Seven
mature male medaka were exposed to E2 for 21 days in 3-L glass beakerscontaining 2 L 100 ng/L E2 in dechlorinated tap water. The test solution was
renewed daily during the experimental period. The fish were fed A. nauplii
(<24 h after hatching) twice a day. Residual bait and feces in the beaker were
removed and the test beaker was cleaned daily. The exposure was performed in a
climate chamber at 24 ± 1°C and with a 16 h:8 h light:dark photoperiod. All fish
were flash-frozen in liquid nitrogen on the last day of exposure and stored at
−80°C for RNA extraction.
Construction of medaka microarray
Four sets of 60-mer oligonucleotide probes for each TIGR OLGI were
designed by GeneFrontier Co. (Tokyo, Japan) based on the data from OLGI,
updated May 16, 2003 (release 4.0). The total number of OLGIs was 22,587,
including 10,085 TCs, 12,333 singleton ESTs, and 169 singleton ETs. The
medaka microarray was synthesized using the MAS (NimbleGen Systems, Inc.)
developed by Singh-Gasson et al. [20]. The medaka array contained 179,972
features for 22,587 OLGIs in duplicate.
Extraction of medaka total RNA
Total RNA from whole frozen medaka was isolated using the Qiagen
RNeasy Lipid Tissue Midi Kit (Qiagen, Inc., Valencia, CA, USA) following
procedures recommended by the manufacturer. Briefly, each frozen medaka was
ground with a mortar and pestle in liquid nitrogen, and half of the homogeneous
powder was mixed vigorously with 5 ml of QIAzol lysis reagent and incubated
for 5 min at room temperature. One milliliter of chloroform was then added to
the homogenate, stirred for approximately 15 s, and incubated for a few minutes
at room temperature. The aqueous layer separated by centrifugation was mixed
thoroughly with 3 ml 70% ethanol and applied to an RNeasy midi spin column.
The column was washed and total RNAwas then eluted in 300 μl of RNase-free
water.
Sample labeling, hybridization, and microarray analysis
Medaka total RNAwas first converted to double-stranded cDNA, followed
by the synthesis of biotin-labeled cRNA using in vitro transcription as
described elsewhere [46,47]. cRNA was then purified and fragmented to an
average size of 50 to 200 bp. Hybridizations were performed with single cRNA
derived from one biosource (one-color hybridization). Hybridization, washing,
and scanning were carried out following standard procedures (NimbleGen
Systems, Inc.). The expression level of each OLGI was calculated by averaging
the intensities of signals from four different probes hybridized to the OLGI.
The signals between each array were normalized using Robust Multichip
Analysis normalization [48–50]. GeneSpring 7.0 (Agilent Technologies, CA,
USA) was used for further expression analysis. OLGIs that showed statistically
significant differences between females and males with or without E2 treatment
were selected by an ANOVAwith Student’s t test (p value cutoff 0.05). To keep
the frequency of false positives low, multiple testing correlation was applied
using the Benjamini and Hochberg test. A post hoc test (Student–Newman–
Keuls) was performed to determine specific differences between pairs of
groups.
RT-PCR
Thirty OLGIs were randomly selected for RT-PCR standards based on their
distribution in the microarray gene expression profile. The sequences of primers
for these 30 OLGIs were the same as the microarray probe sequences except for
one primer from a sequence outside the probe for both protamine and β-actin.
The forward and reverse primers are listed in Table 2. Total RNA prepared for
the microarray analysis was used as template for the RT-PCR experiments. RT-
PCR was performed using the StrataScript First-Strand Synthesis System
(Stratagene, La Jolla, CA, USA). The cDNA solution was diluted 20 times, and
2 μl of each dilution was used for 20 μl scale PCR with TaKaRa Ex Taq HS
(TaKaRa, Shiga, Japan). Each amplification reaction was resolved on a 2%
agarose gel and visualized with EtBr staining. Bands were detected and
quantified using the ATTO densitograph system (Lane & Spot Analyzer version
6) (ATTO Corp., Tokyo, Japan).
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